Neurogene Inc (NGNE)
Healthcare
Biotechnology
—
32.90 $
-2.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Neurogene Inc (NGNE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -77 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18 | -20 | -30 | -45 | -32 | -15 | -25 | -46 | -53 | -51 | -71 | -77 | |
| 0.1 | – | – | – | – | 0.3 | 1.8 | 0.9 | 3.2 | 3.3 | 3.2 | 3.1 | |
| – | – | – | – | – | – | – | 0.9 | 1.3 | 1.4 | 8.3 | 14 | |
| 3.6 | -0.5 | 4.7 | 0.9 | -5.4 | -2.0 | 1.0 | 1.6 | -2.7 | -4.0 | -6.0 | 0.3 | |
| 0.1 | 0.0 | 0.7 | 0.5 | 0.0 | 0.9 | 2.2 | 18 | 2.2 | 0.3 | 0.8 | 1.2 | |
| -24 | -48 | -48 | 64 | 56 | -0.7 | -2.2 | -18 | -2.2 | 26 | -125 | 14 | |
| – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | |
| 45 | 93 | 71 | 0.4 | 0.6 | 82 | 77 | 51 | 67 | 92 | 184 | 30 | |
| – | – | -7.2 | 20 | 25 | 66 | 49 | -14 | 11 | 67 | -12 | -33 | |
| -18 | -20 | -31 | -45 | -32 | -16 | -27 | -65 | -55 | -52 | -71 | -78 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.